Milestone Pharmaceuticals Inc. (MIST:NASDAQ) closed at $0.691 on October 27, 2026, up 7.26% on the day. The stock trades 77.4% below its 52-week high of $3.06 and 9.5% above its 52-week low of $0.631. Over the past year, it lost 62.2%. Milestone Pharmaceuticals Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 27, 2025, MIST closed higher on 104 days (41%). Its best day was March 31, 2026 (+17.82%) and its worst was March 20, 2026 (-20.00%). The stock moved 10% or more in a single session 13 times.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
Find more stocks like MIST with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.